Sime Diagnostics
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
43 Manchester St, London, Greater London...Website
www.simedx.comRevenue
$5.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Sime Diagnostics
SIME Diagnostics specializes in AI-powered point-of-care diagnostics for intensive care, focusing on acute respiratory diseases. Their patented platform includes a compact, cloud-connected device and reagent-free disposables designed for use in neonatal and adult intensive care units. The company's first product is a rapid test for neonatal lung maturity, providing results within 15 minutes to inform critical treatment decisions. SIME aims to improve patient outcomes and reduce healthcare costs by delivering fast, precise diagnostics that support better clinical interventions.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sime Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Sime Diagnostics launches new products
Check out if Sime Diagnostics is spiking on competitors!
Check if Sime Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Sime Diagnostics
Click to see if Sime Diagnostics had a recent Job posting/layoffs
Sime Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Sime Diagnostics has new funding data
Earning: See what the market has to say on Sime Diagnostics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Sime Diagnostics as Masked Content
Find more new buyers
Compare Similar Companies to Sime Diagnostics
Compare insights from companies similar to Sime Diagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Sime Diagnostics
$5.5M
11-50
Private
-
2014
N/A
Company Profile Activity
Activity Insights
Sime Diagnostics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sime Diagnostics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sime Diagnostics.
Sime Diagnostics Tech Stack
A closer look at the technologies used by Sime Diagnostics
See more technologies
Sime Diagnostics News & Media
SIME begins Clinical Trial validating point-of-care device that rapidly predicts neonatal respiratory disease at birth in the NICU
The FAST 2 (Fourier-transform Infrared Spectroscopy guided Surfactant Therapy) trial begins in 4 Danish University Hospitals to validate performance of innovative point-of-care (POC) device LONDON, Feb. 7, 2023 /PRNewswire/ -- SIME Diagnostics, a pioneer in point-of-care respiratory...SIME AI device that predicts acute respiratory disease receives CE Mark - changing the standard of care for millions of babies worldwide
The point-of-care device, which predicts severe lung disease in the ICU and NICU, has been CE marked for investigational use LONDON, Nov. 14, 2022 /PRNewswire/ -- SIME Diagnostics, a pioneer in point-of-care respiratory diagnostics in the ICU, today announced the successful CE-IVD...SIME strengthens board to prepare for commercialisation
Morten Henneveld, a life science executive with decades of commercial and operations experience, joins SIME board as company prepares for Clinical AI Platform product launch in 2023. LONDON, Oct. 19, 2022 /PRNewswire/ -- SIME Diagnostics, a pioneer in point-of-care respiratory diagnostics...SIME Announces Publication of Clinical Study Demonstrating Reduced Pulmonary Surfactant in COVID-19 ARDS patients
LONDON, March 10, 2022 /PRNewswire/ -- SIME Diagnostics, a commercial stage company pioneering rapid intensive care diagnostics, today announced the publication of a peer-reviewed study demonstrating that the company's point-of-care AI platform can identify ARDS patients with low...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sime Diagnostics
Sign Up For FreeTo access detailed company insights
SIME Diagnostics specializes in AI-powered point-of-care diagnostics for intensive care, focusing on acute respiratory diseases. Their patented platform includes a compact, cloud-connected device and reagent-free disposables designed for use in neonatal and adult intensive care units. The company's first product is a rapid test for neonatal lung ma... Read More
